HARBOR
Research Project |
|
A randomized, double-blind, placebo-controlled phase 2/3 study of elenestinib in indolent systemic mastocytosis
Members (1)
UNIverse - Public Research Portal
Research Project
A randomized, double-blind, placebo-controlled phase 2/3 study of elenestinib in indolent systemic mastocytosis